The Experts below are selected from a list of 225 Experts worldwide ranked by ideXlab platform

D Smith - One of the best experts on this subject based on the ideXlab platform.

  • Percutaneous Drainage of tubo-ovarian abscesses.
    Radiology, 1992
    Co-Authors: Giovanna Casola, Eric Vansonnenberg, H B D'agostino, C P Harker, R R Varney, D Smith
    Abstract:

    The authors performed Percutaneous Drainage of 27 tubo-ovarian abscesses (TOAs) in 16 patients in whom medical therapy with triple antibiotics prior to catheter Drainage had not been successful. Percutaneous Drainage was successful in 15 of 16 patients (94%). One patient underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy 3 days after catheter placement because of persistent symptoms and lack of Drainage from the catheter; at laparotomy, a large infected phlegmon was found. Two patients had recurrent disease at 3 and 4 months after catheter placement. Bilateral salpingectomy was performed in one patient and total abdominal hysterectomy and bilateral salpingo-oophorectomy in the other. One of these patients had cervical carcinoma, and the other had a long history of recurrent pelvic inflammatory disease and TOAs. The long-term avoidance of surgery was 81.2%. Access routes for catheter Drainage were through the anterior abdominal wall for 10 abscesses, through the posterior transgluteal route for 11, and through the transvaginal route for six. Duration of Drainage was 1-20 days (mean, 6 days). Complications consisted of transient sciatic pain in two patients and mild bacteremia in one. The results indicate that Percutaneous Drainage of TOAs is effective in patients in whom medical therapy is not successful.

H B D'agostino - One of the best experts on this subject based on the ideXlab platform.

  • Treatment of pancreatic pseudocysts with Percutaneous Drainage and octreotide. Work in progress.
    Radiology, 1993
    Co-Authors: H B D'agostino, Eric Vansonnenberg, R B Sanchez, Brian W. Goodacre, R G Villaveiran, K Lyche
    Abstract:

    In an attempt to decrease catheter Drainage of pancreatic pseudocysts, a combined regimen of Percutaneous Drainage and administration of octreotide acetate was used in eight symptomatic patients. Indications for the combined therapy were pseudocyst recurrence (four patients), pancreatic fistula from Percutaneous Drainage (two patients), or elective treatment to restrict pancreatic Drainage. Octreotide acetate was administered subcutaneously in doses of 50-1,000 micrograms three times a day. The drug was well tolerated and produced only limited adverse effects in four patients: pain at the injection site, hypoglycemia, diarrhea, headaches, and lower-extremity edema (more than one adverse effect was experienced by each patient). The combined use of Percutaneous Drainage and administration of octreotide was effective in seven patients and failed in one patient who had distal pancreatic duct occlusion. In five patients, catheter Drainage decreased to no measurable amount by a mean of 13.8 days. These results ...

  • Percutaneous Drainage of tubo-ovarian abscesses.
    Radiology, 1992
    Co-Authors: Giovanna Casola, Eric Vansonnenberg, H B D'agostino, C P Harker, R R Varney, D Smith
    Abstract:

    The authors performed Percutaneous Drainage of 27 tubo-ovarian abscesses (TOAs) in 16 patients in whom medical therapy with triple antibiotics prior to catheter Drainage had not been successful. Percutaneous Drainage was successful in 15 of 16 patients (94%). One patient underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy 3 days after catheter placement because of persistent symptoms and lack of Drainage from the catheter; at laparotomy, a large infected phlegmon was found. Two patients had recurrent disease at 3 and 4 months after catheter placement. Bilateral salpingectomy was performed in one patient and total abdominal hysterectomy and bilateral salpingo-oophorectomy in the other. One of these patients had cervical carcinoma, and the other had a long history of recurrent pelvic inflammatory disease and TOAs. The long-term avoidance of surgery was 81.2%. Access routes for catheter Drainage were through the anterior abdominal wall for 10 abscesses, through the posterior transgluteal route for 11, and through the transvaginal route for six. Duration of Drainage was 1-20 days (mean, 6 days). Complications consisted of transient sciatic pain in two patients and mild bacteremia in one. The results indicate that Percutaneous Drainage of TOAs is effective in patients in whom medical therapy is not successful.

Eric Vansonnenberg - One of the best experts on this subject based on the ideXlab platform.

  • Treatment of pancreatic pseudocysts with Percutaneous Drainage and octreotide. Work in progress.
    Radiology, 1993
    Co-Authors: H B D'agostino, Eric Vansonnenberg, R B Sanchez, Brian W. Goodacre, R G Villaveiran, K Lyche
    Abstract:

    In an attempt to decrease catheter Drainage of pancreatic pseudocysts, a combined regimen of Percutaneous Drainage and administration of octreotide acetate was used in eight symptomatic patients. Indications for the combined therapy were pseudocyst recurrence (four patients), pancreatic fistula from Percutaneous Drainage (two patients), or elective treatment to restrict pancreatic Drainage. Octreotide acetate was administered subcutaneously in doses of 50-1,000 micrograms three times a day. The drug was well tolerated and produced only limited adverse effects in four patients: pain at the injection site, hypoglycemia, diarrhea, headaches, and lower-extremity edema (more than one adverse effect was experienced by each patient). The combined use of Percutaneous Drainage and administration of octreotide was effective in seven patients and failed in one patient who had distal pancreatic duct occlusion. In five patients, catheter Drainage decreased to no measurable amount by a mean of 13.8 days. These results ...

  • Percutaneous Drainage of tubo-ovarian abscesses.
    Radiology, 1992
    Co-Authors: Giovanna Casola, Eric Vansonnenberg, H B D'agostino, C P Harker, R R Varney, D Smith
    Abstract:

    The authors performed Percutaneous Drainage of 27 tubo-ovarian abscesses (TOAs) in 16 patients in whom medical therapy with triple antibiotics prior to catheter Drainage had not been successful. Percutaneous Drainage was successful in 15 of 16 patients (94%). One patient underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy 3 days after catheter placement because of persistent symptoms and lack of Drainage from the catheter; at laparotomy, a large infected phlegmon was found. Two patients had recurrent disease at 3 and 4 months after catheter placement. Bilateral salpingectomy was performed in one patient and total abdominal hysterectomy and bilateral salpingo-oophorectomy in the other. One of these patients had cervical carcinoma, and the other had a long history of recurrent pelvic inflammatory disease and TOAs. The long-term avoidance of surgery was 81.2%. Access routes for catheter Drainage were through the anterior abdominal wall for 10 abscesses, through the posterior transgluteal route for 11, and through the transvaginal route for six. Duration of Drainage was 1-20 days (mean, 6 days). Complications consisted of transient sciatic pain in two patients and mild bacteremia in one. The results indicate that Percutaneous Drainage of TOAs is effective in patients in whom medical therapy is not successful.

Giovanna Casola - One of the best experts on this subject based on the ideXlab platform.

  • Percutaneous Drainage of tubo-ovarian abscesses.
    Radiology, 1992
    Co-Authors: Giovanna Casola, Eric Vansonnenberg, H B D'agostino, C P Harker, R R Varney, D Smith
    Abstract:

    The authors performed Percutaneous Drainage of 27 tubo-ovarian abscesses (TOAs) in 16 patients in whom medical therapy with triple antibiotics prior to catheter Drainage had not been successful. Percutaneous Drainage was successful in 15 of 16 patients (94%). One patient underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy 3 days after catheter placement because of persistent symptoms and lack of Drainage from the catheter; at laparotomy, a large infected phlegmon was found. Two patients had recurrent disease at 3 and 4 months after catheter placement. Bilateral salpingectomy was performed in one patient and total abdominal hysterectomy and bilateral salpingo-oophorectomy in the other. One of these patients had cervical carcinoma, and the other had a long history of recurrent pelvic inflammatory disease and TOAs. The long-term avoidance of surgery was 81.2%. Access routes for catheter Drainage were through the anterior abdominal wall for 10 abscesses, through the posterior transgluteal route for 11, and through the transvaginal route for six. Duration of Drainage was 1-20 days (mean, 6 days). Complications consisted of transient sciatic pain in two patients and mild bacteremia in one. The results indicate that Percutaneous Drainage of TOAs is effective in patients in whom medical therapy is not successful.

Zuo Chang-jing - One of the best experts on this subject based on the ideXlab platform.

  • CT guided Percutaneous Drainage in treatment of solitary retroperitoneai abscess
    Journal of Interventional Radiology, 2007
    Co-Authors: Zuo Chang-jing
    Abstract:

    Objective To evaluate the therapeutic efficacy of Percutaneous Drainage of solitary retroperitoneal abscess under CT guidance.Methods A retrospective analysis was made for Percutaneous Drainage of solitary retroperitoneal abscess with CT guidance in 13 patients including 4 at the tail of pancreas, 3 nearby the head of pancreas,3 in perirenal space,2 in posterior renal space and 1 case was by the side of psoas muscle.The maximum diameters of retroperitoneal abscess were between 3.5cm and 8cm.Results Out of 13 patients,8 with one time Drainage,3 with twice Drainages and 2 with thrice Drainages.The mean duration of Drainage was 16 days with no recurrence or residual lesions during clinical follow up.Conclusion CT guided Percutaneous Drainage of solitary retroperitoneal abscess is effective and minimally invasive.(J Intervent Radiol,2007,16:828-830)